First data of a quabodepistat containing novel regimen for drug-susceptible tuberculosis

Lancet Infect Dis. 2024 Nov 26:S1473-3099(24)00653-4. doi: 10.1016/S1473-3099(24)00653-4. Online ahead of print.
No abstract available